The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy

2018 ◽  
Vol 25 (6) ◽  
pp. 1312-1320 ◽  
Author(s):  
Ahmet S Boşnak ◽  
Nevzat Birand ◽  
Ömer Diker ◽  
Abdikarim Abdi ◽  
Bilgen Başgut
Keyword(s):  
Clinical Pharmacy ◽  
Treatment Effectiveness ◽  
University Hospital ◽  
Major Type ◽  
Cancer Type ◽  
Pharmacy Services ◽  
Drug Related Problems ◽  
Clinical Pharmacy Services ◽  
Treatment Safety

Background Clinical pharmacists have important roles in implementing scientifically valid knowledge and advice on safe, reasonable use of pharmaceuticals. Clinical pharmacy services were introduced and evaluated in oncology clinic in a tertiary university hospital. Methods A prospective interventional study was conducted from November 2017 to March 2018. Drug-related problems were classified using the Pharmaceutical Care Network Europe drug-related problem classification tool v8.01. The main outcome measure is the proposed interventions aimed at identification of the drug-related problems, the role of the pharmacists in the resolution, and the rate of acceptance of these recommendations by physicians. Results A total of 102 patients were included in the study, who were treated with at least two cycles of any cancer type and stage. A total of 55 (53.9%) patients had 251 drug-related problems. Drug-related problems mainly involved antihypertensive (31.6%), antidiabetic (17.8%), and herbal agents (31.6%). Treatment effectiveness was the major type of drug-related problems (50.2%) followed by treatment safety (29.1%). A total of 211 (100%) interventions were accepted and regarded as clinically relevant. Prescriber informed only were the most common types of intervention at the prescriber level. Eighty-six point four percent identified drug-related problems were solved, 9.8% of the problems were partially solved, 2.3% problems were unsolved. Conclusion Clinical pharmacy services may have optimized therapy effectiveness, prevent adverse effects and unclear/compliant problems. The pharmacist interventions were highly acknowledged by oncologists and patients; this may indicate the presence of a great convenience and need to implement Clinical pharmacy services in alternative hospitals in Northern Cyprus.

scholarly journals Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital

2022 ◽  
Vol 22 (1) ◽  
Author(s):  
Aslınur Albayrak ◽  
Bilgen Başgut ◽  
Gülbin Aygencel Bıkmaz ◽  
Bensu Karahalil
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Clinical Pharmacy ◽  
Clinical Pharmacist ◽  
University Hospital ◽  
Pharmacy Services ◽  
Drug Related Problems ◽  
Electrolyte Disorders ◽  
Drug Induced ◽  
Clinical Pharmacy Services

Abstract Background Critically ill patients treated in the intensive care units (ICUs) often suffer from side effects and drug-related problems (DRPs) that can be life-threatening. A way to prevent DRPs and improve drug safety and efficacy is to include clinical pharmacists in the clinical team. This study aims to evaluate the classification of drug-related problems and the implementation of clinical pharmacy services by a clinical pharmacist in the ICU of a university hospital in Turkey. Methods This study was carried out prospectively between December 2020 and July 2021 in Gazi University Medical Faculty Hospital Internal Diseases ICU. All patients hospitalized in the intensive care unit for more than 24 h were included in the study. During the study, the clinical pharmacist's interventions and other clinical services for patients were recorded. DRPs were classed according to the Pharmaceutical Care Network Europe V.8.02. Results A total of 151 patients were included during the study period corresponding to 2264 patient-days. Patients with DRPs had a longer hospital stay and a higher mortality rate (p < 0.05). 108 patients had at least one DRP and the total number of DRPs was 206. There was an average of 1.36 DRPs per patient, 71.5% of patients experienced DRP and 89.22 DRPs per 1000 patient-days. A total of 35 ADEs were observed in 32 patients. ADE incidence was per 1000 patient-days 15.45. ADEs were caused by nephrotoxicity (48.57%), electrolyte disorders (17.14%), drug-induced thrombocytopenia (17.14%), liver enzyme increase (8.57%) and other causes (8.57%). Drug selection (40.29%) and dose selection (54.36%) constituted most of the causes of DRPs. Dose change was the highest percentage of planned interventions with a rate of 56.79%. Intervention was accepted at a rate of 90.8% and it was fully implemented. Conclusion In this study, the importance of the clinical pharmacist in the determination and analysis of DRPs was emphasized. Clinical pharmacy services like the one described should be implemented widely to increase patient safety.

scholarly journals Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China

2019 ◽  
Vol 41 (6) ◽  
pp. 1570-1577
Author(s):  
Yulin Zhu ◽  
Cheng Liu ◽  
Yong Zhang ◽  
Qingping Shi ◽  
Yiqiu Kong ◽  
...  
Keyword(s):  
Treatment Effectiveness ◽  
Mainland China ◽  
Tertiary Hospital ◽  
University Hospital ◽  
Patient Treatment ◽  
Major Type ◽  
Respiratory Care ◽  
Drug Related Problems ◽  
Patient Counseling ◽  
Treatment Safety

Abstract Background The prevalence of drug-related problems in patients hospitalized at respiratory care units is unknown in mainland China. Objective To identify and categorize drug-related problems in a respiratory care unit in China. Setting Respiratory care unit in a tertiary university hospital in China. Methods Clinical pharmacy services were introduced and documented during an 18-months study period. The problems were categorized using the Pharmaceutical Care Network Europe DRP classification tool V8.02. Main outcome measures Problems and causes of drug-related problems, interventions proposed, and outcome of pharmacy recommendations. Results A total of 474 patients were reviewed, 164 patients had DRPs (34.6%). Total 410 problems were identified, an average of 2.5 per patient. Treatment effectiveness was the major type of problem detected (219; 53.4%) followed by treatment safety (140; 34.1%). The most common causes of the problems were patient-related (25.8%), drug selection (24.0%), and drug use process (23.4%). Pharmacist made 773 interventions; average 1.9 per drug-related problem. A total of 96.2% of these interventions were accepted leading to solving 81.9% of the identified problems. Conclusion There is a high prevalence of drug-related problems in patients hospitalized at the respiratory unit of this clinic. Clinical pharmacists should focus on improving prescribing practice and patient counseling.

Clinical pharmacy services in an ambulatory oncology clinic: Patient perception and satisfaction

2020 ◽  
pp. 107815522095041
Author(s):  
Lauren Munro ◽  
Glenn Myers ◽  
Odette Gould ◽  
Michael LeBlanc
Keyword(s):  
Clinical Pharmacy ◽  
Qualitative Data ◽  
Patient Perception ◽  
Mixed Methods Study ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Telephone Interviews ◽  
Patient Interviews ◽  
Ambulatory Oncology

Introduction Studies have shown that patients rate pharmacists more favourably when the pharmacist expresses interest in the patient and attends to patients’ perspectives. There is limited available evidence evaluating both patient perception and satisfaction regarding clinical pharmacy services provided in an ambulatory oncology clinic. Methods This was a prospective mixed methods study involving surveys and patient interviews. Consenting participants completed a survey at their first visit evaluating their perceptions of the importance of the clinical pharmacy services offered in the ambulatory oncology clinic. They completed a second survey 6-8 weeks later to re-evaluate their perceptions and to measure satisfaction ratings. The final component of this study involved semi-structured one-on-one telephone interviews to gather qualitative data regarding the study objectives. Results A total of 35 participants completed the survey, of which eleven completed one-on-one patient telephone interviews. Patients perceived the clinical pharmacy services assessed as important to their care before receiving treatment. The ratings of the importance of the pharmacist in managing patients’ nausea/vomiting significantly decreased when remeasured, whereas the importance of meeting the pharmacist in the clinic significantly increased. The importance of the role of the pharmacist was highlighted in patient interviews as well: patients particularly valued the pharmacist’s initiative to meet them in the clinic, the education provided by pharmacist, and the pharmacist’s accessibility throughout treatment. Conclusions Overall, patients in the ambulatory oncology clinic perceived the services offered as important to their care and they were highly satisfied.

Determination of the Drug Information Needs of the Medical Staff of a Nigerian Hospital following Implementation of Clinical Pharmacy Services

1987 ◽  
Vol 21 (9) ◽  
pp. 748-751 ◽  
Author(s):  
Ene I. Ette ◽  
Judy I. Achumba ◽  
Esther A. Brown-Awala
Keyword(s):  
Clinical Pharmacy ◽  
Information Needs ◽  
Drug Information ◽  
University Hospital ◽  
Patient Specific ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Working Day ◽  
Nigerian University ◽  
High Degree

The types and frequency of questions asked of clinical pharmacists introducing clinical pharmacy services in the internal medicine wards of a Nigerian university hospital and the degree of compliance with pharmacists' recommendations were studied. Three faculty pharmacists collected data in two 30-working day study periods, separated by a year. Totals of 197 questions (an average of 6.57 ± 1.33 questions/working day) and 271 questions (an average of 9.03 ± 1.10 questions/working day) were answered by the pharmacists in the first and second study periods, respectively. Pharmacists recommended changes in patient-specific drug therapy that were implemented 52 percent and 69 percent of the time in the first and second study periods, respectively. The most common type of drug information request concerned the presence or the likelihood of an adverse drug reaction. Continuous interaction between pharmacists and physicians in the patient-care setting results in a better appreciation of the pharmacist's role as drug information consultant, and the consequence of this is a high degree of compliance with pharmacists' recommendations.

Introducing clinical pharmacy services to cardiovascular clinics at a university hospital in Northern Cyprus

2017 ◽  
Vol 39 (6) ◽  
pp. 1185-1193 ◽  
Author(s):  
Haider Al-Baghdadi ◽  
Çiğdem Koca Al-Baghdadi ◽  
Abdikarim Abdi ◽  
Onur Gültekin ◽  
Arijana Meštrović ◽  
...  
Keyword(s):  
Clinical Pharmacy ◽  
University Hospital ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Northern Cyprus

scholarly journals Implementing ward based clinical pharmacy services in an Ethiopian University Hospital

2013 ◽  
Vol 11 (1) ◽  
pp. 51-57 ◽  
Author(s):  
Alemayehu B. Mekonnen ◽  
Elias A. Yesuf ◽  
Peggy S. Odegard ◽  
Sultan S. Wega
Keyword(s):  
Clinical Pharmacy ◽  
University Hospital ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services

Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic

2011 ◽  
Vol 17 (4) ◽  
pp. 387-394 ◽  
Author(s):  
Megan McKee ◽  
Bradi L Frei ◽  
Anita Garcia ◽  
David Fike ◽  
Scott A Soefje
Keyword(s):  
Clinical Pharmacy ◽  
Demographic Data ◽  
Counseling Services ◽  
Pharmacy Services ◽  
Cross Sectional Survey ◽  
Survey Tool ◽  
Clinical Pharmacy Services ◽  
Medication Therapy ◽  
The Impact

Background. Assessing the role of the pharmacist in an outpatient oncology clinic requires quantification of parameters that are important to the patient and the healthcare system. Patient evaluations not only serve as benchmarks for a process; but may also predict behavior such as utilization of care, continuity with the provider, and compliance. Purpose. To identify the role of the patient–pharmacist relationship and enhance patient satisfaction with care, a survey tool was developed and utilized. Methods. A 20-item, 2-page survey tool was developed and administered to oncology patients actively receiving treatment at the Cancer Therapy & Research Center (CTRC) in San Antonio, Texas. Following approval from the Investigational Review Board, survey distribution began on December 1, 2009 and continued through February 2010. Basic social and demographic data were collected. Satisfaction with pharmacy service was assessed with questions on a Likert ranking scale detailing time spent with pharmacists, knowledge of medication therapy, willingness to pay for clinical pharmacy services, etc. The primary outcome was the impact of the pharmacist–patient relationship assessed by examining the interaction between time spent with pharmacist, understanding of medications, and desire for future pharmacy counseling services. Results. A total of 77 surveys were administered and collected. Of the patients surveyed, 86% stated that it is important for patients to discuss their treatment with a pharmacist and 76% requested pharmacy follow-up at future visits. Conclusion. This cross-sectional survey reveals that patients are interested in visiting with a pharmacist regularly during chemotherapy treatment and patients may be willing to pay for pharmacy counseling services.

scholarly journals PERCEPTIONS OF PHYSICIANS ABOUT CLINICAL PHARMACIST’S ROLE IN AL QASSIM’S HOSPITALS IN SAUDI ARABIA

2017 ◽  
Vol 17 (3) ◽  
pp. 109-116
Author(s):  
Nahid Osman Ahmed ◽  
Mahfoudh A. M. Abdulghani ◽  
Sarah Fahad Alrebdi ◽  
Mohammed Faez Baobaid
Keyword(s):  
Clinical Pharmacy ◽  
Healthcare Professionals ◽  
Response Rate ◽  
Pharmacy Services ◽  
Medication History ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Clinical Pharmacy Services ◽  
Clinical Pharmacists

The objective of this study is to explore physician’s perception toward clinical pharmacy services and role of clinical pharmacists in governmental hospitals at Al-Qassim region. An observational cross-sectional survey was conducted. Results: 150 males and 39 females participated giving 75.5% (189 of 250) response rate. Physicians perceptions were found to be high (equal or more than 90% of frequency) in some clinical pharmacy services such as patients’ education and counselling, monitoring of patients’ responses to drug therapy including toxicity/side effects and provision of drug information to healthcare professionals. The physicians showed low perception (less than 76%) in the taking of patients’ medication history on admission, by clinical pharmacists. Conclusion: Physicians’ perception toward clinical pharmacy services and the role of clinical pharmacists was not found to be completely favourable. The reason of this mixed responses and to the accommodating feelings of clinical pharmacy services in clinical setting appear to relate to the state of infrastructure and environments of hospitals. The infrastructure and environments of hospitals need to be updated for an improved accommodation clinical pharmacy services.

Sign in / Sign up

Export Citation Format

Share Document